Cart (0 Items)
Your cart is currently empty.
View ProductsIt looks like you are visiting from outside the EU. Switch to the US version to see local pricing in USD and local shipping.
Switch to US ($)
| Size | 100ug, 1MG |
|---|---|
| Isotype | IgG4, kappa |
| Brand | ProteoGenix |
| Product type | Primary Antibodies |
| Clonality | Monoclonal Antibody |
| Expression system | Mammalian cells |
| Applications | Elisa, WB |
| Product name | Trevogrumab Biosimilar - Anti-MSTN, GDF8 mAb - Research Grade |
|---|---|
| Source | CAS 1429201-24-0 |
| Species | Homo sapiens |
| Expression system | Mammalian cells |
| Purity | >85% |
| Buffer | PBS buffer PH7.5 |
| Delivery condition | Blue ice (+4°C) |
| Delivery lead time in business days | 3-5 days if in stock; 3-5 weeks if production needed |
| Delivery Time | 3-5 days if in stock; 3-5 weeks if production needed |
| Storage condition | store at -80°C |
| Brand | ProteoGenix |
| Aliases /Synonyms | Trevogrumab,REGN-1033, REGN1033, SAR-391786,MSTN, GDF8,anti-MSTN, GDF8 |
| Reference | PX-TA1388 |
| Note | For research use only. Not suitable for clinical or therapeutic use. |
| Isotype | IgG4, Kappa |
Trevogrumab has been investigated for the treatment of Orthopedic disease and Sarcopenia.
Trevogrumab Biosimilar - Anti-MSTN, GDF8 mAb, on SDS-PAGE under reducing and non-reducing condition. The gel was stained overnight with Coomassie Blue. The purity of the antibody is greater than 95%.
Related products
Got a question or need a quote?
Message us and we’ll get back to you 48 hours or less.
Reviews
There are no reviews yet.